Amcasertib (BBI-503) is an oral first-in-class cancer stemness kinase inhibitor. By targeting multiple serine-threonine stemness kinases, amcasertib inhibits Nanog and other cancer stemness pathways.
Molecular Weight:
539.69
Purity:
>99%
CAS Number:
[1129403-56-0]
Formula:
C31H33N5O2S
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted